| LGG (n = 9) | HGG (n = 18) |
---|---|---|
Sex (male: female) | 3: 6 | 9: 9 |
Age (years) | 48.3 ± 12.2 | 52.3 ± 13.0 |
Histologic feature | ||
 Glioblastoma (WHO IV) |  | 14 |
 Anaplastic Astrocytomas (WHO III) |  | 2 |
 Anaplastic Oligodendroglioma (WHO III) |  | 1 |
 Anaplastic Oligoastrocytoma (WHO III) |  | 1 |
 Diffuse astrocytomas (WHO II) | 6 |  |
 Oligodendrogliomas (WHO II) | 3 |  |
Enhancement pattern | ||
 Markedly heterogeneous enhancement |  | 13 |
 Local Enhancement | 2 | 3 |
 Non-enhancement | 7 | 2 |
Number of lesion | ||
 Single lesion | 9 | 16 |
 Multiple lesion | 0 | 2 |